Birmingham Heartlands Hospital

Site:	Birmingham Heartlands Hospital
Address:
City:	Birmingham
State:
Zip:	B9 5SS
Country:	UK

Phase	Trial	Trial Status	Site Status [asc]	Drug	NCT#
3	Phase III, Open-Label Study of Nilotinib Versus Imatinib in GIST Patients (ENESTg1)	Completed	Closed	Nilotinib or Imatinib	NCT00785785
3	Three Versus Five Years of Adjuvant Imatinib as Treatment of Patients With Operable GIST	Active, not recruiting	Closed	Imatinib	NCT02413736